NeoGenomics Stock In A Range-Bound Matrix, Weakness Likely Until 2026

NeoGenomics (NASDAQ: NEO) is in Phase 18, the final stage of its Adhishthana Cycle on the weekly charts. After more than 850 days of consolidation, the stock shows little sign of breaking out. When analysed under the lens of the Adhishthana Principles, NEO seems to have taken the blue pill, stuck in the Matrix of range-bound trading until August 2026.

Read the full article on Benzinga for deeper insights into the Adhishthana Cycle, the stock’s recent trajectory, and expert commentary.